In a new study funded University of Delaware researchers from multiple disciplines assessed the challenges of the coordinated community response systems serving victims of domestic violence during the height of the COVID-19 pandemic. Through interviews with domestic violence coalition leaders, they find that the pandemic uniquely disrupted the infrastructure for service coordination, the continuity of law enforcement and legal systems, the maintenance of evidence-based practices and more.

Persistently low rates of COVID-19 vaccination in Black and Hispanic children suggest that parents in these communities tend to be hesitant about the vaccine for their kids, even when they have received it themselves. Through interviews with parents of school-aged children, a new study sheds light on the factors influencing decisions about vaccination. Findings were published in the June issue of the Vaccine: X journal.

When a person coughs or sneezes, they expel a cloud of microscopic particles capable of carrying viruses and bacteria that act as vectors for respiratory diseases such as flu, COVID-19 or tuberculosis. Understanding how these aerosols disperse in the air is crucial for minimising the transmission of pathogens in indoor spaces, but their dynamics are complex and depend on many factors: the force of the exhalation, the morphology of the respiratory system, the characteristics of the space, etc. Now, a new study led by researchers from the Universitat Rovira i Virgili has shown that temperature also plays an important role.

Samuel Kruger, associate professor of finance; John Griffin, James A. Elkins Centennial Chair in Finance; and doctoral student Prateek Mahajan found that fraud in government-funded pandemic loans explained 22.5% of the average increase in housing prices during 2020 and 2021.

Study results could lead to new therapeutic solutions

A new Mass General Brigham-led study using AI to analyze electronic health records found that long COVID may be twice as common as current estimates, affecting more than 18 million Americans. The findings reveal major gaps in diagnostic coding-based surveillance, with more than 10 million cases likely uncounted and prevalence continuing to grow over time.

The risk of being hospitalized or dying from COVID-19 infection was lower among adults with better heart health scores. Adults without cardiovascular disease and with the best levels of heart health, as indexed by the American Heart Association’s Life’s Essential 8 heart health metric, were nearly half as likely to develop severe COVID-19 when compared to adults with the worst levels of heart health. Specifically, the Life’s Essential 8 components of better physical activity, body mass index, blood pressure and sleep were associated with most-reduced risk.

 U.S. prevalence of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), a multisystem neurologic disease and debilitating chronic condition, averaged 1 million to 2.5 million before the COVID-19 pandemic. Incidence rates are now reported to be 15 times greater, related at least in part to long COVID. This retrospective chart review analyzed records of medications and supplements tried before specialty consultation from 571 adults with ME/CFS seen at a Mayo Clinic specialty clinic from 2018 to 2022.

In a new study published in Nature Immunology, researchers at Boston Children’s Hospital demonstrated that pairing the original COVID-19 mRNA vaccine with an immune system enhancer, known as an adjuvant, improved the duration of the vaccine’s protection in mice. The combo also showed a more pronounced response against omicron viral components than the vaccine alone. The researchers say that introducing adjuvants like this one to mRNA vaccines may alleviate the need for frequent boosters due to waning antibodies or new viral variants.